Giulia Errico

Dr. Giulia Errico

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
MGMaria Giufrè
Maria Giufrè
GEGiulia Errico
Giulia Errico
MAMarisa Accogli
Marisa Accogli
MMMonica Monaco
Monica Monaco
LVLaura Villa
Laura Villa
MCMarina Cerquetti
Marina Cerquetti

6 November 2018 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
ASArtur J. Sabat
Artur J. Sabat
MTMarco Tinelli
Marco Tinelli
HGHajo Grundmann
Hajo Grundmann
VAViktoria Akkerboom
Viktoria Akkerboom
MMMonica Monaco
Monica Monaco
AFAlex Friedrich
Alex Friedrich
Objectives: Daptomycin (DAP) resistance in Staphylococcus aureus is uncommon but there are increasing reports of the emergence of resistance during DAP therapy. Most clinical DAP-resistant S. aureus isolates investigated carried mutations in the mprF gene. The aim of this study was to identify mutations between a clinical pair of methicillin-susceptible S. aureus (MSSA) isolates (DAP-susceptible and DAP-resistant). Additionally, the activity of genes previously associated with DAP resistance was assessed. Materials and Methods: Two MSSA isolates from patient with left-sided endocarditis were analyzed by whole genome sequencing (WGS) and reverse transcription-quantitative real-time PCR (RT-qPCR). The first isolate, DAP-susceptible, was obtained before initiation of treatment and the second isolate, DAP-resistant, was recovered after 4 weeks of DAP therapy. Results: Comparison of complete genomes of DAP-susceptible and its DAP-resistant variant identified two non-synonymous and one synonymous mutations. The non-synonymous mutations consisted of a S829L substitution in mprF and a T331I substitution in vraS. The RT-qPCR experiments revealed an increased expression of vraS, dltA, mprF, and sceD genes in DAP-resistant variant. Strikingly, the expression of dltA and mprF genes was significantly downregulated by DAP. Conclusion: The mprF and vraS genes were previously associated with DAP resistance, however, none of the mutations described in this study had been previously identified and linked to DAP resistance. Moreover, we provide a new insight into the DAP action on S. aureus, in which the expression of key genes in DAP resistance is decreased by the antibiotic.

29 January 2018 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
Aurora Garcia-FernandezAurora Garcia-Fernandez
Aurora Garcia-Fernandez
CGCarlo Gagliotti
Carlo Gagliotti
FMFilomena Morsillo
Filomena Morsillo
MMMaria Luisa Moro
Maria Luisa Moro
LMLucia Masiero
Lucia Masiero
ACAlessandro Nanni Costa
Alessandro Nanni Costa

29 May 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
MGMaria Giufre
Maria Giufre
GEGiulia Errico
Giulia Errico
MGMaria Del Grosso
Maria Del Grosso
MPMichela Pagnotta
Michela Pagnotta
BPBernardetta Palazzotti
Bernardetta Palazzotti
MMMonica Monaco
Monica Monaco
Background: Carbapenemase-producing Klebsiella pneumoniae (CP-KP) represents a global threat to public health, with limited antimicrobial therapeutic options. In this study, we analyzed a ceftazidime/avibactam (CAZ-AVI)-resistant K. pneumoniae isolate obtained from a patient previously exposed to CAZ-AVI expressing a novel K. pneumoniae carbapenemase (KPC)-3 variant. Methods: Antimicrobial susceptibility testing was performed using reference broth microdilution. Whole-genome sequencing (WGS) was performed using Illumina and Nanopore Technologies. Short- and long-reads were combined with Unicycler. Assemblies were investigated for multilocus sequence typing (MLST), antimicrobial resistance genes, porins, and plasmids. Results: The K. pneumoniae isolate (KP_RM_1) was resistant to CAZ-AVI, expanded-spectrum cephalosporins, amikacin, ertapenem, and cefiderocol (FDC) but was susceptible to tigecycline, colistin, trimethoprim/sulfamethoxazole, meropenem–vaborbactam, and imipenem–relebactam. WGS revealed that the KP_RM_1 genome is composed of a single chromosome of 5 Mbp and five circular plasmids. Further analysis showed the presence of novel blaKPC-216 located on a 72 kb plasmid. KPC-216 differs from KPC-3 by a Lysin (K) insertion at position 168 (+K168). Conclusions: We report the identification of a new KPC-3 variant associated with CAZ-AVI resistance. The KPC variants associated with CAZ-AVI resistance should be determined to promptly inform clinicians and start the appropriate antimicrobial therapy.

24 June 2017 in Infection
Verified
Journal Article
Closed access
PDF file
MMMonica Monaco
Monica Monaco
ASAnna Rita Sacchi
Anna Rita Sacchi
MSMarzia Scotti
Marzia Scotti
FMFabiola Mancini
Fabiola Mancini
CRCarlo Riccio
Carlo Riccio
APAnnalisa Pantosti
Annalisa Pantosti

3 August 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
MGMaria Giufre
Maria Giufre
GEGiulia Errico
Giulia Errico
MMMonica Monaco
Monica Monaco
MGMaria Del Grosso
Maria Del Grosso
Michela SabbatucciMichela Sabbatucci
Michela Sabbatucci
MTMarco Tinelli
Marco Tinelli
The spread of carbapenemase-producing (CP) Enterobacterales is currently a worldwide concern, especially in the elderly. Twelve CP-E. coli isolated from rectal swabs of colonized inpatients aged ≥65 years from four hospitals in two Italian cities (Milan and Rome) were analyzed by whole genome sequencing (WGS) to obtain multi-locus sequence typing (MLST), identification of carbapenemase-encoding genes, resistome, plasmid content, and virulence genes. MLST analysis showed the presence of 10 unrelated lineages: ST410 (three isolates from three different hospitals in two cities) and ST12, ST38, ST69, ST95, ST131, ST189, ST648, ST1288, and ST1598 (one isolate each). Most isolates (9/12, 75%) contained a serine-β-lactamase gene (5 blaKPC-3, 2 blaKPC-2, and 2 blaOXA-181), while three isolates harbored a metallo-β-lactamase gene (two blaNDM-5 and one blaVIM-1). In most CP-E. coli, the presence of more than one plasmid was observed, with the predominance of IncF. Several virulence genes were detected. All isolates contained genes enhancing the bacterial fitness, such as gad and terC, and all isolates but one, fimH, encoding type 1 fimbriae. In conclusion, CP-E. coli clones colonizing elderly patients showed heterogeneous genetic backgrounds. We recommend strict surveillance to monitor and prevent the spread of successful, high-risk clones in healthcare settings.